Effectiviteit van de ‘Ziektelastmeter COPD’: Een clustergerandomiseerde gecontroleerde trail

O C P van Schayck; Annerika Gidding - Slok; D Kotz; G van Breukelen; N H Chavannes; M P M H Rutten-van Mölken; H A M Kerstjens; T van der Molen; G M Asijee; P N R Dekhuijzen; S Holverda; P L Salomé; Lucas M A Goossens; M Twellaar; J C C M In 't Veen

Effectiviteit van de ‘Ziektelastmeter COPD’: Een clustergerandomiseerde gecontroleerde trail

Translated title of the contribution: Effectiveness of the Assessment of Burden of COPD tool: a cluster-randomised controlled trial

O C P van Schayck, Annerika Gidding - Slok, D Kotz, G van Breukelen, N H Chavannes, M P M H Rutten-van Mölken, H A M Kerstjens, T van der Molen, G M Asijee, P N R Dekhuijzen, S Holverda, P L Salomé, Lucas M A Goossens, M Twellaar, J C C M In 't Veen

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

OBJECTIVE: Assessment of the effectiveness of the Assessment of Burden of COPD (ABC) tool on disease-specific quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD).

DESIGN: Cluster-randomised controlled trial.

METHOD: This concerned a trial in 39 Dutch primary care practices and 17 hospitals, involving 357 patients with COPD (postbronchodilator FEV1/FVC ratio < 0.7) aged ≥ 40 years. Healthcare providers were randomized to an intervention or control group. Patients in the intervention group were treated with the ABC tool. This innovative tool consists of a short validated questionnaire and a number of objective parameters, which collectively give a visual overview of the combined integral health; the tool subsequently produces an individualized treatment plan by means of a treatment algorithm. Patients in the control group received usual care. The primary outcome measure was the proportion of patients with a clinically relevant improvement in disease-specific quality of life measured, as measured by means of the St. George's Respiratory Questionnaire (SGRQ) score, between baseline and 18 months follow-up. Secondary outcomes included the SGRQ total score and the Patient Assessment of Chronic Illness Care (PACIC) score.

RESULTS: At 18-month follow-up, a significant and clinically relevant improvement in the SGRQ score was seen in 34% of the patients (N=49) in the intervention group, and in the control group this figure was 22% (N=33). This difference between the two groups was significant (OR 1.85, 95% CI 1.08 to 3.16). Patients in the intervention group experienced a higher quality of care than patients in the control group (0.32 points difference in PACIC, 95% CI 0.14 to 0.50).

CONCLUSION: Use of the ABC tool increases the disease-specific quality of life and the quality of care for COPD patients; it may therefore offer a valuable contribution to improvements in the daily care of COPD. Replication of this study in other (non-Dutch) health-care settings is recommended.

Translated title of the contribution	Effectiveness of the Assessment of Burden of COPD tool: a cluster-randomised controlled trial
Original language	Dutch
Article number	D955
Journal	Nederlands Tijdschrift voor Geneeskunde
Volume	160
Publication status	Published - 2016

Access to Document

https://www.ntvg.nl/system/files/publications/d955_erratum.pdf

Cite this

van Schayck, O. C. P., Gidding - Slok, A., Kotz, D., van Breukelen, G., Chavannes, N. H., Rutten-van Mölken, M. P. M. H., Kerstjens, H. A. M., van der Molen, T., Asijee, G. M., Dekhuijzen, P. N. R., Holverda, S., Salomé, P. L., Goossens, L. M. A., Twellaar, M., & In 't Veen, J. C. C. M. (2016). Effectiviteit van de ‘Ziektelastmeter COPD’: Een clustergerandomiseerde gecontroleerde trail. Nederlands Tijdschrift voor Geneeskunde, 160, Article D955. https://www.ntvg.nl/system/files/publications/d955_erratum.pdf

@article{d3ef15e53df647249b2742ec11331ea7,

title = "Effectiviteit van de {\textquoteleft}Ziektelastmeter COPD{\textquoteright}: Een clustergerandomiseerde gecontroleerde trail",

abstract = "OBJECTIVE: Assessment of the effectiveness of the Assessment of Burden of COPD (ABC) tool on disease-specific quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD).DESIGN: Cluster-randomised controlled trial.METHOD: This concerned a trial in 39 Dutch primary care practices and 17 hospitals, involving 357 patients with COPD (postbronchodilator FEV1/FVC ratio < 0.7) aged ≥ 40 years. Healthcare providers were randomized to an intervention or control group. Patients in the intervention group were treated with the ABC tool. This innovative tool consists of a short validated questionnaire and a number of objective parameters, which collectively give a visual overview of the combined integral health; the tool subsequently produces an individualized treatment plan by means of a treatment algorithm. Patients in the control group received usual care. The primary outcome measure was the proportion of patients with a clinically relevant improvement in disease-specific quality of life measured, as measured by means of the St. George's Respiratory Questionnaire (SGRQ) score, between baseline and 18 months follow-up. Secondary outcomes included the SGRQ total score and the Patient Assessment of Chronic Illness Care (PACIC) score.RESULTS: At 18-month follow-up, a significant and clinically relevant improvement in the SGRQ score was seen in 34% of the patients (N=49) in the intervention group, and in the control group this figure was 22% (N=33). This difference between the two groups was significant (OR 1.85, 95% CI 1.08 to 3.16). Patients in the intervention group experienced a higher quality of care than patients in the control group (0.32 points difference in PACIC, 95% CI 0.14 to 0.50).CONCLUSION: Use of the ABC tool increases the disease-specific quality of life and the quality of care for COPD patients; it may therefore offer a valuable contribution to improvements in the daily care of COPD. Replication of this study in other (non-Dutch) health-care settings is recommended.",

author = "{van Schayck}, {O C P} and {Gidding - Slok}, Annerika and D Kotz and {van Breukelen}, G and Chavannes, {N H} and {Rutten-van M{\"o}lken}, {M P M H} and Kerstjens, {H A M} and {van der Molen}, T and Asijee, {G M} and Dekhuijzen, {P N R} and S Holverda and Salom{\'e}, {P L} and Goossens, {Lucas M A} and M Twellaar and {In 't Veen}, {J C C M}",

year = "2016",

language = "Dutch",

volume = "160",

journal = "Nederlands Tijdschrift voor Geneeskunde",

issn = "0028-2162",

publisher = "Bohn Stafleu van Loghum",

}

van Schayck, OCP , Gidding - Slok, A, Kotz, D, van Breukelen, G, Chavannes, NH, Rutten-van Mölken, MPMH, Kerstjens, HAM, van der Molen, T, Asijee, GM, Dekhuijzen, PNR, Holverda, S, Salomé, PL, Goossens, LMA, Twellaar, M & In 't Veen, JCCM 2016, 'Effectiviteit van de ‘Ziektelastmeter COPD’: Een clustergerandomiseerde gecontroleerde trail', Nederlands Tijdschrift voor Geneeskunde, vol. 160, D955. <https://www.ntvg.nl/system/files/publications/d955_erratum.pdf>

TY - JOUR

T1 - Effectiviteit van de ‘Ziektelastmeter COPD’

T2 - Een clustergerandomiseerde gecontroleerde trail

AU - van Schayck, O C P

AU - Gidding - Slok, Annerika

AU - Kotz, D

AU - van Breukelen, G

AU - Chavannes, N H

AU - Rutten-van Mölken, M P M H

AU - Kerstjens, H A M

AU - van der Molen, T

AU - Asijee, G M

AU - Dekhuijzen, P N R

AU - Holverda, S

AU - Salomé, P L

AU - Goossens, Lucas M A

AU - Twellaar, M

AU - In 't Veen, J C C M

PY - 2016

Y1 - 2016

N2 - OBJECTIVE: Assessment of the effectiveness of the Assessment of Burden of COPD (ABC) tool on disease-specific quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD).DESIGN: Cluster-randomised controlled trial.METHOD: This concerned a trial in 39 Dutch primary care practices and 17 hospitals, involving 357 patients with COPD (postbronchodilator FEV1/FVC ratio < 0.7) aged ≥ 40 years. Healthcare providers were randomized to an intervention or control group. Patients in the intervention group were treated with the ABC tool. This innovative tool consists of a short validated questionnaire and a number of objective parameters, which collectively give a visual overview of the combined integral health; the tool subsequently produces an individualized treatment plan by means of a treatment algorithm. Patients in the control group received usual care. The primary outcome measure was the proportion of patients with a clinically relevant improvement in disease-specific quality of life measured, as measured by means of the St. George's Respiratory Questionnaire (SGRQ) score, between baseline and 18 months follow-up. Secondary outcomes included the SGRQ total score and the Patient Assessment of Chronic Illness Care (PACIC) score.RESULTS: At 18-month follow-up, a significant and clinically relevant improvement in the SGRQ score was seen in 34% of the patients (N=49) in the intervention group, and in the control group this figure was 22% (N=33). This difference between the two groups was significant (OR 1.85, 95% CI 1.08 to 3.16). Patients in the intervention group experienced a higher quality of care than patients in the control group (0.32 points difference in PACIC, 95% CI 0.14 to 0.50).CONCLUSION: Use of the ABC tool increases the disease-specific quality of life and the quality of care for COPD patients; it may therefore offer a valuable contribution to improvements in the daily care of COPD. Replication of this study in other (non-Dutch) health-care settings is recommended.

AB - OBJECTIVE: Assessment of the effectiveness of the Assessment of Burden of COPD (ABC) tool on disease-specific quality of life in patients with Chronic Obstructive Pulmonary Disease (COPD).DESIGN: Cluster-randomised controlled trial.METHOD: This concerned a trial in 39 Dutch primary care practices and 17 hospitals, involving 357 patients with COPD (postbronchodilator FEV1/FVC ratio < 0.7) aged ≥ 40 years. Healthcare providers were randomized to an intervention or control group. Patients in the intervention group were treated with the ABC tool. This innovative tool consists of a short validated questionnaire and a number of objective parameters, which collectively give a visual overview of the combined integral health; the tool subsequently produces an individualized treatment plan by means of a treatment algorithm. Patients in the control group received usual care. The primary outcome measure was the proportion of patients with a clinically relevant improvement in disease-specific quality of life measured, as measured by means of the St. George's Respiratory Questionnaire (SGRQ) score, between baseline and 18 months follow-up. Secondary outcomes included the SGRQ total score and the Patient Assessment of Chronic Illness Care (PACIC) score.RESULTS: At 18-month follow-up, a significant and clinically relevant improvement in the SGRQ score was seen in 34% of the patients (N=49) in the intervention group, and in the control group this figure was 22% (N=33). This difference between the two groups was significant (OR 1.85, 95% CI 1.08 to 3.16). Patients in the intervention group experienced a higher quality of care than patients in the control group (0.32 points difference in PACIC, 95% CI 0.14 to 0.50).CONCLUSION: Use of the ABC tool increases the disease-specific quality of life and the quality of care for COPD patients; it may therefore offer a valuable contribution to improvements in the daily care of COPD. Replication of this study in other (non-Dutch) health-care settings is recommended.

M3 - Article

C2 - 27805538

SN - 0028-2162

VL - 160

JO - Nederlands Tijdschrift voor Geneeskunde

JF - Nederlands Tijdschrift voor Geneeskunde

M1 - D955

ER -